SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-006492
Filing Date
2023-12-27
Accepted
2023-12-27 16:22:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4060
  Complete submission text file 0001950047-23-006492.txt   5412
Mailing Address 3200 WALNUT ST BOULDER CO 80301
Business Address
MOORE JOHN R (Reporting) CIK: 0001191702 (see all company filings)

Type: 144

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40236 | Film No.: 231518251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)